FDA Will Make Its Case for LDT Oversight at Tuesday Hearing

Devices & Diagnostics Letter
A A
CDRH Director Jeffrey Shuren will defend the FDA’s proposal to regulate laboratory-developed tests during a Sept. 9 hearing on Capitol Hill.

To View This Article:

Login

Subscribe To Devices & Diagnostics Letter

Buy This Article Now

Add this article to your cart for $25.00